000 01495 a2200421 4500
005 20250514051123.0
264 0 _c20030122
008 200301s 0 0 eng d
022 _a0269-9370
024 7 _a10.1097/00002030-200211080-00012
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMiller, John
245 0 0 _aA randomized, double-blind study of gemfibrozil for the treatment of protease inhibitor-associated hypertriglyceridaemia.
_h[electronic resource]
260 _bAIDS (London, England)
_cNov 2002
300 _a2195-200 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
650 0 4 _aDiet
650 0 4 _aDouble-Blind Method
650 0 4 _aFemale
650 0 4 _aGemfibrozil
_xadverse effects
650 0 4 _aHIV Infections
_xdrug therapy
650 0 4 _aHIV Protease Inhibitors
_xadverse effects
650 0 4 _aHumans
650 0 4 _aHypertriglyceridemia
_xchemically induced
650 0 4 _aHypolipidemic Agents
_xadverse effects
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aTreatment Outcome
700 1 _aBrown, Dannae
700 1 _aAmin, Janaki
700 1 _aKent-Hughes, Julia
700 1 _aLaw, Matthew
700 1 _aKaldor, John
700 1 _aCooper, David A
700 1 _aCarr, Andrew
773 0 _tAIDS (London, England)
_gvol. 16
_gno. 16
_gp. 2195-200
856 4 0 _uhttps://doi.org/10.1097/00002030-200211080-00012
_zAvailable from publisher's website
999 _c12217927
_d12217927